Advances in cardiovascular science are moving faster than ever — and one of the most talked-about breakthroughs today involves CRISPR gene-editing technology. You may have seen headlines suggesting that a single injection could permanently reduce "bad" cholesterol by up to 50%. But what does this really mean for patients, and how close are we to seeing this in everyday heart care?
At Cardiovascular Consultants, we believe in separating scientific promise from clinical reality — so let's take a closer look.
CRISPR (short for Clustered Regularly Interspaced Short Palindromic Repeats) is a powerful gene-editing technology that allows scientists to precisely "edit" DNA. In cardiovascular research, CRISPR is being studied as a way to turn off specific genes involved in cholesterol production, particularly those that raise LDL cholesterol — the type often referred to as "bad cholesterol."
One key target is a gene called PCSK9, which plays a role in how the body clears LDL cholesterol from the blood.
Early human clinical trials have shown promising results:
This approach is fundamentally different from daily medications like statins or periodic injections such as PCSK9 inhibitors — it aims to be a one-time therapy.
Not yet. While the science is exciting, CRISPR-based cholesterol treatments are still in early clinical trial phases, being closely evaluated for long-term safety, and not approved for routine clinical use. Gene editing is irreversible, which means researchers must be extremely careful to ensure there are no unintended side effects over time.
Today, patients can effectively manage cholesterol with proven therapies such as lifestyle changes (nutrition, exercise, weight management), statins, ezetimibe, PCSK9 inhibitor injections, and combination therapies tailored to individual risk. These treatments are safe, effective, and evidence-based — and they remain the gold standard in cardiovascular care.
Even though CRISPR therapies are not yet available, this research represents an important shift in how we think about heart disease: moving from lifelong treatment to potential one-time solutions, targeting disease at its genetic root, and offering hope for patients with genetic or treatment-resistant high cholesterol.
At Cardiovascular Consultants, we stay at the forefront of emerging research while delivering the highest standard of care today. Science is advancing. Your heart health starts now.
Questions about your heart health?
Our board-certified cardiologists are here to help at three Metro Detroit locations.
Call (586) 698-1200